Susquehanna International Group, LLP Novo Nordisk A S Transaction History
Susquehanna International Group, LLP
- $568 Billion
- Q1 2024
A detailed history of Susquehanna International Group, LLP transactions in Novo Nordisk A S stock. As of the latest transaction made, Susquehanna International Group, LLP holds 1,075,682 shares of NVO stock, worth $146 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,075,682
Previous 189,015
469.1%
Holding current value
$146 Million
Previous $19.6 Million
606.37%
% of portfolio
0.02%
Previous 0.0%
Shares
24 transactions
Others Institutions Holding NVO
# of Institutions
1,851Shares Held
309MCall Options Held
5.29MPut Options Held
4.93M-
Jennison Associates LLC21.1MShares$2.85 Billion1.82% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.7MShares$1.86 Billion0.83% of portfolio
-
Bank Of America Corp Charlotte, NC13.1MShares$1.77 Billion0.16% of portfolio
-
Morgan Stanley New York, NY12MShares$1.62 Billion0.13% of portfolio
-
Fayez Sarofim & CO Houston, TX11.8MShares$1.6 Billion4.6% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $305B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...